Literature DB >> 11079543

Alteration of the serotonergic nervous system in fatal familial insomnia.

J Wanschitz1, S Klöppel, C Jarius, P Birner, H Flicker, J A Hainfellner, P Gambetti, M Guentchev, H Budka.   

Abstract

Fatal familial insomnia (FFI) is a unique hereditary prion disease with characteristic disturbances of sleep. We studied the serotonergic system in 8 FFI-affected subjects by immunohistochemistry for the serotonin-synthesizing enzyme, tryptophan hydroxylase (TH). Quantification of neurons in median raphe nuclei showed no total neuronal loss in FFI but a substantial increase of TH+ neurons (approximately 62%) in FFI subjects compared with controls. Our data indicate an alteration of the serotonergic system that might represent the functional substrate of some typical symptoms of FFI.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11079543

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  5 in total

1.  [Fatal familial insomnia: case presentation and discussion of typical clinical and imaging findings].

Authors:  A V Thomas; J C Klein; A Brockhaus-Dumke; W D Heiss; A H Jacobs; H F Petereit
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

2.  A roadmap for investigating the role of the prion protein in depression associated with neurodegenerative disease.

Authors:  Danielle Beckman; Rafael Linden
Journal:  Prion       Date:  2016-03-03       Impact factor: 3.931

Review 3.  Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations.

Authors:  Franc Llorens; Juan-José Zarranz; Andre Fischer; Inga Zerr; Isidro Ferrer
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

4.  Metals and Circadian Rhythms.

Authors:  Nancy L Parmalee; Michael Aschner
Journal:  Adv Neurotoxicol       Date:  2017-09-01

5.  Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice.

Authors:  Danielle Beckman; Luis E Santos; Tatiana A Americo; Jose H Ledo; Fernando G de Mello; Rafael Linden
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.